Back

Feasibility and efficacy of acetazolamide in the treatment of acute decompensated heart failure

31 August 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Heart failure therapy: new insights Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yu Iemura

Saitama Medical Center, Kawagoe (Japan)

7 More presentations in this session

Presentation thumbnail
Treatment with flozins across the whole spectrum of heart failure in Poland between February 2022 and June 2023 based on Heart Failure Observational Study by Polish Cardiac Society..
Doctor R. Morawiec (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Efficacy of acetazolamide as adjunct therapy in improving fluid management in patients with acute congestive heart failure: a systematic review and meta-analysis of randomized controlled trials
Doctor I. Tolentino Narciso (Montes Claros, BR)
Abstract Slides Video
Presentation thumbnail
The efficacy of IV iron in anemic heart failure patients: a systemic review and meta-analysis of randomised controlled trials.
Doctor A. Al Qurm (JO)
Abstract Slides Video
Presentation thumbnail
Effects of anakinra on patients with heart failure below and above 60 years of age
Doctor M. Golino (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Continuation of beta-blockers at discharge is associated with improved outcome in patients with HFpEF and concomitant moderate aortic stenosis
Doctor M. Shumkova (Sofia, BG)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure therapy: new insights

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Combination oral acetazolamide and intravenous furosemide on acute decompensated heart failure
thumbnail
Congress Presentation
Acetazolamide for patients with acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials
thumbnail
Congress Presentation
Acetazolamide - we need more evidence before primetime: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources